Compare Divis Laboratories with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES STRIDES PHARMA SCIENCE DIVIS LABORATORIES/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 37.9 -7.4 - View Chart
P/BV x 10.5 1.0 1,054.8% View Chart
Dividend Yield % 0.5 0.8 66.9%  

Financials

 DIVIS LABORATORIES   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
STRIDES PHARMA SCIENCE
Mar-21
DIVIS LABORATORIES/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3,9131,000 391.3%   
Low Rs1,824304 600.3%   
Sales per share (Unadj.) Rs262.5369.7 71.0%  
Earnings per share (Unadj.) Rs74.739.6 188.5%  
Cash flow per share (Unadj.) Rs84.462.6 134.7%  
Dividends per share (Unadj.) Rs20.002.50 800.0%  
Avg Dividend yield %0.70.4 181.8%  
Book value per share (Unadj.) Rs350.1309.1 113.3%  
Shares outstanding (eoy) m265.4789.68 296.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x10.91.8 619.7%   
Avg P/E ratio x38.416.4 233.4%  
P/CF ratio (eoy) x34.010.4 326.7%  
Price / Book Value ratio x8.22.1 388.4%  
Dividend payout %26.86.3 424.3%   
Avg Mkt Cap Rs m761,51758,465 1,302.5%   
No. of employees `000NANA-   
Total wages/salary Rs m8,2585,501 150.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m69,69433,159 210.2%  
Other income Rs m627734 85.4%   
Total revenues Rs m70,32133,893 207.5%   
Gross profit Rs m28,6116,702 426.9%  
Depreciation Rs m2,5562,063 123.9%   
Interest Rs m211,501 1.4%   
Profit before tax Rs m26,6603,872 688.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,818317 2,154.0%   
Profit after tax Rs m19,8433,555 558.1%  
Gross profit margin %41.120.2 203.1%  
Effective tax rate %25.68.2 312.8%   
Net profit margin %28.510.7 265.5%  
BALANCE SHEET DATA
Current assets Rs m67,90628,172 241.0%   
Current liabilities Rs m17,28427,383 63.1%   
Net working cap to sales %72.62.4 3,053.1%  
Current ratio x3.91.0 381.9%  
Inventory Days Days10165 5.8%  
Debtors Days Days878122 720.6%  
Net fixed assets Rs m45,96339,996 114.9%   
Share capital Rs m531897 59.2%   
"Free" reserves Rs m92,41526,823 344.5%   
Net worth Rs m92,94627,719 335.3%   
Long term debt Rs m08,826 0.0%   
Total assets Rs m113,86968,168 167.0%  
Interest coverage x1,270.53.6 35,488.0%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.60.5 125.8%   
Return on assets %17.47.4 235.2%  
Return on equity %21.312.8 166.4%  
Return on capital %28.714.7 195.3%  
Exports to sales %051.1 0.0%   
Imports to sales %18.80-   
Exports (fob) Rs mNA16,941 0.0%   
Imports (cif) Rs m13,127NA-   
Fx inflow Rs m58,87735,084 167.8%   
Fx outflow Rs m13,341392 3,404.4%   
Net fx Rs m45,53634,692 131.3%   
CASH FLOW
From Operations Rs m19,4694,814 404.4%  
From Investments Rs m751-5,208 -14.4%  
From Financial Activity Rs m-349-158 220.9%  
Net Cashflow Rs m19,872-564 -3,523.4%  

Share Holding

Indian Promoters % 51.9 30.3 171.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 36.8 38.5 95.6%  
FIIs % 18.5 19.7 93.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 69.4 69.3%  
Shareholders   309,397 133,190 232.3%  
Pledged promoter(s) holding % 0.0 57.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 236 Points Lower, Nifty Falls Below 16,150; IT & FMCG Stocks Witness Selling(Closing)

Indian share markets ended on a negative note today as global cues remained weak.

Related Views on News

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

The Most Oversold Stocks in India. Is it Finally Time to Get in? (Views On News)

Jan 7, 2022

With the help of relative strength index (RSI), we take a look at top stocks that are oversold at current levels.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


May 24, 2022 03:31 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS